Showing results for stivarga
Refine
x
closeconditions |
First Liver Cancer Rx in Almost 10 Years
May 8, 2017
The US Food and Drug Administration (FDA) has approved the first medication to treat liver cancer in nearly 10 years.
Stivarga
Stivarga is a prescription medication used to treat colon or rectal cancer that has spread (metastasized) in adults. It is also used to treat a type of tumor that occurs in the stomach or small intestine and is approved to treat a type of liver cancer called hepatocellular carcinoma (HCC).
Stivarga belongs to a group of drugs called kinase inhibitors, which prev...
FDA Approves New GIST Rx
February 25, 2013
The US Food and Drug Administration has approved a medication to treat gastrointestinal stromal tumors (GIST) that can’t be removed with surgery, have spread or no longer respond to existing therapies.
FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors
February 25, 2013
The US Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.
Punching Gut Cancer
December 13, 2012
A cancer you don’t hear about much attacks the tissues that connect digestive organs. These are called GIST, which is easier to say than "gastrointestinal stromal tumors". Scientists have found a drug that helps kicks GIST in the gut.
A Chat With The Makers Of New Colorectal Cancer Drug
September 28, 2012
People living with colorectal cancer that has spread to other areas of the body now have a new therapy option. Unlike so many late-stage cancer treatments, this isn’t an intravenous drug - rather, a tablet.
FDA approves new treatment for advanced colorectal cancer
September 27, 2012
The US Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).